heltzen investor CEO of eXoZymes to Present at ThinkEquity’s Annual Investor Conference Oct 23, 2025 4:31:14 PM
heltzen press clippings Podcast: 'The Catalyst' interviews CEO, Michael Heltzen Oct 17, 2025 12:30:00 PM
press clippings video World Bio Markets: AI - A tool U.S. industrial biomanufacturing cannot ignore Oct 8, 2025 5:01:26 PM
heltzen press clippings Podcast: 'Inside Biotech' interviews CEO, Michael Heltzen Oct 2, 2025 4:31:07 PM
press release science Driving the cell-free revolution: eXoZymes leaders join BioMADE Leadership & Technical Committees Sep 30, 2025 4:11:01 PM
press release investor eXoZymes provides second quarter 2025 update at 5PM EST today Aug 12, 2025 4:28:01 PM
press release investor eXoZymes to host second quarter 2025 update on Tuesday August 12, 2025, at 5PM EST Aug 7, 2025 4:15:00 PM
press release investor nutraceuticals video science eXoZymes details biomanufacturing breakthrough: 4 grams of NCT with over 99% purity Jul 29, 2025 7:57:00 AM
.png?width=1024&height=1024&name=Screenshot%202025-09-15%20at%2017.42.51%20(2).png)
.jpg?width=1024&height=1024&name=Damien+NCT(thumbnail).jpg)